Abstract
P-156 Outcomes of a bortezomib-based induction regimen (sequential or upfront triple association with lenalidomide) in transplant-eligible patients withh newly diagnosed multiple myeloma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have